Literature DB >> 10378399

Chronic respiratory morbidity following premature delivery--prediction by prolonged respiratory support requirement?

M Kinali1, A Greenough, G Dimitriou, B Yüksel, R Hooper.   

Abstract

UNLABELLED: Neonatal chronic lung disease (CLD) is usually diagnosed if an infant remains oxygen dependent beyond 36 weeks postconceptional age (PCA). Our aim was to determine whether a shorter duration of respiratory support accurately predicted subsequent respiratory morbidity. A total of 103 infants, median gestational age 29 weeks (range 23-35), were followed prospectively for 5 years. They had a birth weight of < 1500 g or, if a birth weight of between 1500 and 2000 g, had required neonatal ventilatory support. Parents completed diary cards; their child had positive symptom status if, in any one year, they coughed and/or wheezed on at least 3 days per week for a 4-week period or for at least 3 days following each upper respiratory tract infection. Subsequent respiratory morbidity, positive symptom status in years 1 and 2 or all 5 pre-school years, was related to various definitions of prolonged respiratory support: intermittent positive pressure ventilation dependence > 7 days; oxygen dependence > 28 days and oxygen dependence > 36 weeks PCA. In years 1 and 2, 25 children were symptomatic and 22 in all 5 years. The patients with subsequent respiratory morbidity were distinguished from those without by requiring longer respiratory support (P < 0.05). Logistic regression analysis demonstrated only oxygen dependence beyond 28 days was independently related to subsequent respiratory morbidity (P < 0.01). The positive predictive values and likelihood ratios (95% confidence intervals) for positive symptom status in all 5 years were for intermittent positive pressure ventilation > 7 days 35% (16-53) and 19.5 (1.01-3.76), for oxygen dependency > 28 days 42% (23-61) and 2.20 (1.45-5.02) and for oxygen dependency >36 weeks PCA 35% (13-58) and 1.67 (0.65-4.31).
CONCLUSION: Oxygen dependency at 28 days of age remains a useful criterion on which to diagnose "neonatal" chronic lung disease.

Entities:  

Mesh:

Year:  1999        PMID: 10378399     DOI: 10.1007/s004310051128

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  Randomised trial of fluid restriction in ventilated very low birthweight infants.

Authors:  V Kavvadia; A Greenough; G Dimitriou; R Hooper
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

2.  Lung volumes in infants who had mild to moderate bronchopulmonary dysplasia.

Authors:  Anne Greenough; Gabriel Dimitriou; Ravindra Y Bhat; Simon Broughton; Simon Hannam; Gerrard F Rafferty; Jaana A Leipälä
Journal:  Eur J Pediatr       Date:  2005-06-04       Impact factor: 3.183

3.  Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease.

Authors:  A Greenough; J Alexander; S Burgess; P A J Chetcuti; S Cox; W Lenney; F Turnbull; N J Shaw; A Woods; J Boorman; S Coles; J Turner
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

4.  Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-01       Impact factor: 2.253

5.  A scoring system to predict chronic oxygen dependency.

Authors:  Caroline May; Valia Kavvadia; Gabriel Dimitriou; Anne Greenough
Journal:  Eur J Pediatr       Date:  2006-08-08       Impact factor: 3.183

6.  Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection.

Authors:  A Greenough; S Cox; J Alexander; W Lenney; F Turnbull; S Burgess; P A Chetcuti; N J Shaw; A Woods; J Boorman; S Coles; J Turner
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

7.  Prediction of respiratory outcome in extremely low gestational age infants.

Authors:  Richard B Parad; Jonathan M Davis; Jessica Lo; Mark Thomas; Neil Marlow; Sandy Calvert; Janet L Peacock; Anne Greenough
Journal:  Neonatology       Date:  2015-03-03       Impact factor: 4.035

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.